LALuqman Alwi

Luqman Alwi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luqman Alwi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spontaneous Pneumothorax after Physical Exertion on Adolescets with Vaping History in Diponegoro National Hospital Semarang: A Case Report

    by Qonita Nur Qolby, Muzaki Wilastono, Hanifa Amalia Balqis, Hadi Hadi, Luqman Alwi

    Background: Vaping is now a trend for a tobacco-smoking alternative. However, studies and regulations regarding the side effects of vaping are limited. Recently, vaping-associated spontaneous pneumothorax cases were reported. Pneumothorax, when air accumulates in the pleural cavity, could progress to an emergency case. It is rarely related to physical exercise.Case Presentation: We found two spontaneous pneumothorax cases in Diponegoro National Hospital that presented with chest pain and cough post-exercise in vaping adolescents. The diagnosis was established based on medical history, physical examination, and chest X-ray. Both patients were treated with water-sealed drainage (WSD) and intensive care.Conclusion: Pneumothorax is an important diagnosis to consider in vaping patients, resulting in long stay and high-cost hospitalization. Vaping-associated spontaneous pneumothorax cases in active adolescents should receive special attention for conducting electronic cigarette studies and regulations in Indonesia.

  • Open Access

    Probiotic and ursodeoxycholic acid combination improves microbial gut dysbiosis and bilirubin levels in cholestatic rats

    by Selamat Budijitno, Aldwin Arwidyardi, Endang S. Lestari, Sigit A. Prasetyo, Muflihaul Mutniroh, Luqman Alwi, Sistiya P. Putra

    Context: Cholestasis is marked by a disturbance in bile flow from the liver and potentially progresses to cirrhosis. Hepatic transplantation is the mainstay of therapy in hepatic cirrhosis, which is a high-cost, time-consuming, and complex procedure. Increasing evidence regarding the major role of gut microbiota in bile acid metabolism has prompted the effort to study probiotics as a potential alternative therapeutic strategy in chronic liver disease. Aims: To explore the effect of probiotic administration on Bifidobacterium, as part of the gut microbiota, and bilirubin levels in mice with cholestasis after biliary duct ligation who received standard ursodeoxycholic acid (UDCA) therapy. Methods: Thirty-five male Sprague Dawley rats were randomly assigned into seven groups: Sham-operated rats as healthy controls, cholestatic rats as negative control, UDCA only, probiotics only, and three groups received UDCA-probiotics on a stratified dose for 21 days. The bile duct ligation (BDL) procedure was used to induce cholestasis. Biochemical analyses were conducted for direct and total bilirubin levels, while Bifidobacterium DNA quantification was assessed with PCR. Results: BDL induces cholestasis, marked by a significant increase in direct and total bilirubin levels. The combination of UDCA-probiotics increased the amount of Bifidobacterium, with the highest dose of probiotics showing the highest amount, and the results were comparable among the other groups. The lowest direct and total bilirubin levels were found in the groups with the highest probiotics dose and UDCA combination. Conclusions: UDCA and probiotic combination significantly improved the amount of Bifidobacterium and bilirubin levels in cholestatic rats.